Hear AtLast Holdings, Inc. (HRAL)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0000 (-11.11%)
At close: Aug 21, 2025
Hear AtLast Holdings Market Cap
Hear AtLast Holdings has a market cap or net worth of $185.06 thousand as of August 22, 2025. Its market cap has decreased by -42.90% in one year.
Market Cap
185.06K
Enterprise Value
n/a
Revenue
93.20K
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since July 18, 2007, Hear AtLast Holdings's market cap has decreased from 173.81M to 185.06K, a decrease of -99.89%. That is a compound annual growth rate of -31.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 185.06K | -3.72% |
| Dec 30, 2024 | 192.22K | -18.46% |
| Dec 29, 2023 | 235.73K | -46.67% |
| Dec 30, 2022 | 441.99K | -26.00% |
| Dec 31, 2021 | 597.27K | 173.47% |
| Dec 31, 2020 | 218.40K | -57.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |